157 related articles for article (PubMed ID: 34733461)
1. Analysis of Multiple Human Tumor Cases Reveals the Carcinogenic Effects of PKP3.
Ruan S; Shi J; Wang M; Zhu Z
J Healthc Eng; 2021; 2021():9391104. PubMed ID: 34733461
[TBL] [Abstract][Full Text] [Related]
2. PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer.
Lim V; Zhu H; Diao S; Hu L; Hu J
Biochem Biophys Res Commun; 2019 Jan; 508(2):646-653. PubMed ID: 30527804
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer.
Qian H; Yuan D; Bao J; Liu F; Zhang W; Yang X; Han G; Huang J; Sheng H; Yu H
Medicine (Baltimore); 2019 Mar; 98(10):e14608. PubMed ID: 30855445
[TBL] [Abstract][Full Text] [Related]
4. Role and function of plakophilin 3 in cancer progression and skin disease.
Zhang Y; Chen J; Tian J; Zhou Y; Liu Y
Cancer Sci; 2024 Jan; 115(1):17-23. PubMed ID: 38048779
[TBL] [Abstract][Full Text] [Related]
5. Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers.
Demirag GG; Sullu Y; Gurgenyatagi D; Okumus NO; Yucel I
Diagn Pathol; 2011 Jan; 6():1. PubMed ID: 21194493
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters.
Papagerakis S; Shabana AH; Depondt J; Gehanno P; Forest N
Hum Pathol; 2003 Jun; 34(6):565-72. PubMed ID: 12827610
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis.
Du Y; Hou S; Chen Z; Li W; Li X; Zhou W
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760912
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients.
Valladares-Ayerbes M; Díaz-Prado S; Reboredo M; Medina V; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Pértega S; Santamarina I; Blanco M; Quindós-Varela M; Figueroa A; Antón-Aparicio LM
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1432-40. PubMed ID: 20501752
[TBL] [Abstract][Full Text] [Related]
9. Plakophilin 3 facilitates G1/S phase transition and enhances proliferation by capturing RB protein in the cytoplasm and promoting EGFR signaling.
Müller L; Keil R; Hatzfeld M
Cell Rep; 2023 Jan; 42(1):112031. PubMed ID: 36689330
[TBL] [Abstract][Full Text] [Related]
10. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Furukawa C; Daigo Y; Ishikawa N; Kato T; Ito T; Tsuchiya E; Sone S; Nakamura Y
Cancer Res; 2005 Aug; 65(16):7102-10. PubMed ID: 16103059
[TBL] [Abstract][Full Text] [Related]
11. Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments.
Gao L; Li X; Guo Q; Nie X; Hao Y; Liu Q; Liu J; Zhu L; Yan L; Lin B
Cancer Cell Int; 2020; 20():509. PubMed ID: 33088217
[TBL] [Abstract][Full Text] [Related]
12. c-Src mediated tyrosine phosphorylation of plakophilin 3 as a new mechanism to control desmosome composition in cells exposed to oxidative stress.
Neuber S; Jäger S; Meyer M; Wischmann V; Koch PJ; Moll R; Schmidt A
Cell Tissue Res; 2015 Mar; 359(3):799-816. PubMed ID: 25501895
[TBL] [Abstract][Full Text] [Related]
13. A catenin of the plakophilin-subfamily, Pkp3, responds to canonical-Wnt pathway components and signals.
Hong JY; Zapata J; Blackburn A; Baumert R; Bae SM; Ji H; Nam HJ; Miller RK; McCrea PD
Biochem Biophys Res Commun; 2021 Jul; 563():31-39. PubMed ID: 34058472
[TBL] [Abstract][Full Text] [Related]
14. Plakophilin 3 phosphorylation by ribosomal S6 kinases supports desmosome assembly.
Müller L; Rietscher K; Keil R; Neuholz M; Hatzfeld M
J Cell Sci; 2020 Apr; 133(8):. PubMed ID: 32122945
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic plakophilin-3 regulates acute tissue-specific and systemic inflammation in mice.
Sklyarova T; van Hengel J; Van Wonterghem E; Libert C; van Roy F; Vandenbroucke RE
Eur J Immunol; 2015 Oct; 45(10):2898-910. PubMed ID: 26173741
[TBL] [Abstract][Full Text] [Related]
16. Plakophilin 3 mediates Rap1-dependent desmosome assembly and adherens junction maturation.
Todorovic V; Koetsier JL; Godsel LM; Green KJ
Mol Biol Cell; 2014 Nov; 25(23):3749-64. PubMed ID: 25208567
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.
Aigner K; Descovich L; Mikula M; Sultan A; Dampier B; Bonné S; van Roy F; Mikulits W; Schreiber M; Brabletz T; Sommergruber W; Schweifer N; Wernitznig A; Beug H; Foisner R; Eger A
FEBS Lett; 2007 Apr; 581(8):1617-24. PubMed ID: 17391671
[TBL] [Abstract][Full Text] [Related]
18. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
Front Immunol; 2022; 13():943389. PubMed ID: 36003381
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.
Takahashi H; Nakatsuji H; Takahashi M; Avirmed S; Fukawa T; Takemura M; Fukumori T; Kanayama H
Urology; 2012 Jan; 79(1):240.e1-8. PubMed ID: 22119253
[TBL] [Abstract][Full Text] [Related]
20. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
